- Home
- ADXN vs JAGX Comparison
ADXN vs JAGX Comparison
Compare ADXN & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- JAGX
- Stock Information
- Founded
- ADXN 2002
- JAGX 2013
- Country
- ADXN Switzerland
- JAGX United States
- Employees
- ADXN N/A
- JAGX N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- JAGX Health Care
- Exchange
- ADXN Nasdaq
- JAGX Nasdaq
- Market Cap
- ADXN 11.3M
- JAGX 9.6M
- IPO Year
- ADXN N/A
- JAGX N/A
- Fundamental
- Price
- ADXN $7.80
- JAGX $0.97
- Analyst Decision
- ADXN Strong Buy
- JAGX
- Analyst Count
- ADXN 1
- JAGX 0
- Target Price
- ADXN $30.00
- JAGX N/A
- AVG Volume (30 Days)
- ADXN 56.3K
- JAGX 304.8K
- Earning Date
- ADXN 11-22-2024
- JAGX 11-13-2024
- Dividend Yield
- ADXN N/A
- JAGX N/A
- EPS Growth
- ADXN N/A
- JAGX N/A
- EPS
- ADXN 0.05
- JAGX N/A
- Revenue
- ADXN $960,641.00
- JAGX $10,480,000.00
- Revenue This Year
- ADXN N/A
- JAGX $32.33
- Revenue Next Year
- ADXN N/A
- JAGX $43.63
- P/E Ratio
- ADXN $1.44
- JAGX N/A
- Revenue Growth
- ADXN N/A
- JAGX N/A
- 52 Week Low
- ADXN $5.00
- JAGX $0.90
- 52 Week High
- ADXN $27.90
- JAGX $30.84
- Technical
- Relative Strength Index (RSI)
- ADXN 31.62
- JAGX 40.43
- Support Level
- ADXN $7.86
- JAGX $0.95
- Resistance Level
- ADXN $9.89
- JAGX $1.20
- Average True Range (ATR)
- ADXN 0.93
- JAGX 0.09
- MACD
- ADXN -0.35
- JAGX -0.00
- Stochastic Oscillator
- ADXN 4.57
- JAGX 23.40
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.